Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows List of

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
152
Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows List of Licensed Partners Following Exclusive Collaboration and License Agreement with SulfoSyn

- Lexaria, a global innovator in drug delivery platforms, just announced an exclusive license to SulfoSyn Limited to use its patented DehydraTECH(TM) technology
- Lexaria will also perform specific DehydraTECH-related manufacturing operations on SulfoSyn’s behalf for an initial term of 2 years
- The license agreement adds to Lexaria’s growing list, which, as of the last two years, includes BevNology LLC, Premier Wellness Science Co. Ltd., and Dehydr8, LLC, among others
- It highlights the superiority of Lexaria’s technology, as further compounded by the 37 patents granted so far

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its latest global, exclusive license to SulfoSyn Limited to use its patented DehydraTECH(TM) technology. This license will allow SulfoSyn to use Lexaria’s technology in non-pharmaceutical uses of sulforaphane worldwide, with the ability to sub-license its rights to other companies (https://nnw.fm/bqCSD ).

This agreement is the product of months of research for the two entities. In late 2022, both Lexaria and SulfoSyn started exploring the applicability of DehydraTECH upon sulforaphane. This Sulphur-rich composite molecule is commonly found in vegetables such as broccoli, kale, and cabbage. The testing established that DehydraTECH did have certain superior qualities on the sulforaphane molecule, a result that showed the technology’s commercial viability, specifically for SulfoSyn.

As a result, SulfoSyn will be at liberty to use the DehydraTECH technology for various non-pharmaceutical uses, including supplements, foods, additives, dietary ingredients, and more. In addition, Lexaria has also been contracted by the company to perform specific DehydraTECH-related manufacturing operations on behalf of SulfoSyn for an initial term of 2 years, an engagement that will see Lexaria increase its revenue.

An up-front cash payment has since been paid by SulfoSyn, with minimum future payments already agreed to. In addition, the licensing agreement will see an ongoing royalty payment generated once the minimum payments are exceeded.

This license agreement with SulfoSyn adds to Lexaria’s growing list, which, in the last two years, includes BevNology LLC, Premier Wellness Science Co. Ltd., and Dehydr8, LLC, among others. Given the company’s focus on licensing its technology to companies worldwide, this latest addition marks a significant milestone while highlighting its current growth trajectory, particularly as it continues to create value for its shareholders.

In addition, this milestone highlights the superiority of Lexaria’s DehydraTECH technology, as further compounded by the patents received so far and the pending patents worldwide. On August 29 and September 26, the company received its latest new patents in Canada, bringing the total number of granted patents to 37. Even so, Lexaria continues to invest heavily in its research and development (“R&D”), exploring the potential usage of its technology in various areas of application, including nicotine replacement, antivirals, cardiovascular drugs, human hormone delivery, CBD, PDE5 inhibitors and more.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://nnw.fm/LEXX

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Lexaria Bioscience Corp. (LEXX) Stock Research Links

LEXX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sceye's Stratospheric Leap: A Revolution in Connectivity

Updated Category News Views 1

Sceye's Game-Changer: Stratospheric Connectivity Breakthrough Every once in a while, a tech leap makes folks sit up straight. Maybe it's the allure of a new gadget or a mind-blowing application that spells out change in big, bold letters. Well, Sceye just lobbed one over the Pacific that's like a stone-cold revolution in the world of connectivity. Imagine a game of chess...

Continue Reading
Nutex Health Breach: Legal Scrutiny and Risks Rise

Updated Category News Views 2

Cyberattack Unravels at Nutex Health Not just another day in the office for Nutex Health. The Houston-based micro-hospital operator, envisioned as a go-to for healthcare with its 28 facilities across 12 states, now finds itself plunged into a data nightmare. On August 24, 2026, they blew the whistle on unauthorized network activity. By August 31, it wasn’t just a minor...

Continue Reading
Claroty Earns Top Marks in OT Security Evaluation

Updated Category News Views 5

A Closer Look at Claroty's Forrester Acclaim The waves of cybersecurity analysis have peeled back again, revealing a shining star—Claroty. The latest third-party evaluations seem to show that this beast of a company isn't just cruising; it's tearing up the operational technology security landscape. Named as both a 'Leader' and a 'Customer Favorite' in The Forrester...

Continue Reading
AB 2529: New Bill Awaits Governor's Decision

Updated Category News Views 4

Legislative Milestone or Just Another Step? Hidden Hills, California is causing a bit of a ripple in the state's legislative waters with Assembly Bill 2529. Now that the bill has sailed through the California Legislature with impressive bipartisan support—it passed the State Senate 39-0 and the Assembly 62-4—it's sitting pretty on the Governor's desk. The question...

Continue Reading
Aardvark Therapeutics Faces Investor Legal Challenges

Updated Category News Views 4

Behind the Screens: Aardvark's Legal Turmoil Oh boy, it's not a pretty sight when a biotech darling like Aardvark Therapeutics (NASDAQ: AARD) hits the skids. We're talking about a major shake-up folks. It seems like just yesterday this company was on the cusp of cracking into new medical terrains, promising hope where there was just uncertainty. But here we are, the...

Continue Reading
Arlo Technologies Faces Possible Fiduciary Breach Probe

Updated Category News Views 1

Shareholder Investigation Shakes Things Up Like a surprise punch straight outta nowhere, Arlo Technologies, Inc. (NYSE: ARLO) finds itself under the magnifying glass of Levi & Korsinsky, LLP. They're sniffing around for possible breaches of fiduciary duties by ARLO's officers and directors. It’s a jolting call for shareholders, who need to stay sharp and not get caught...

Continue Reading
CORE CEO Charts New Growth Path in Organ Donation

Updated Category News Views 2

Embracing New Horizons in Organ Donation In a whirlwind of change and commitment, Deborah Maurer steps up as CORE's new CEO, aiming to bring a fresh perspective to the organization's storied history. With her extensive experience at the transplant frontline, she's no rookie. She's got ambitions to shake things up, focusing on collaboration and innovation within the...

Continue Reading
IdentityIQ Expands Language Access With Spanish Launch

Updated Category News Views 4

Breaking Language Barriers in Financial Wellness Identity protection and financial tools are only useful if you can understand them. That's the cold, hard truth that the folks over at IdentityIQ seem to grasp now. They've cottoned on to the fact that more than 41 million Spanish-dominant speakers in the U.S. need access to their services. You can announce all the fancy...

Continue Reading
2026 Mighty 25: Celebrating Military Community Leaders

Updated Category News Views 2

A Spotlight on Unsung Heroes Tampa, Florida, just got a little mightier as We Are The Mighty rolls out the red carpet for the 2026 Mighty 25. This annual roll call, backed by CareSource Military & Veterans™, shines a light on veterans, military spouses, creators, entrepreneurs, and change agents defying the status quo. They are redefining impact across the military...

Continue Reading
Teamsters Strike Hits Amazon's Largest U.S. Warehouse

Updated Category News Views 8

Unrest Brewing in Riverside: Amazon's Labor Showdown September 1, 2026, marks a potentially seismic shift in labor disputes within one of America's corporate titans—Amazon. Picture this: workers slinging on their boots, not for a day of hauling goods in Amazon's largest U.S. warehouse, DJT6, but for a united stand outside its gates. Who's at the helm? The Teamsters...

Continue Reading

Top 5 Most Recently Viewed Articles

Here Group Limited Reports Impressive Q1 Fiscal Results

Updated Category News Views 136

Here Group Limited's Financial Results Highlights Here Group Limited (NASDAQ: HERE) has revealed its unaudited financial results for the first quarter of Fiscal Year 2026, showcasing significant achievements and advancements within its pop toy business. This critical report encompasses the financial period from July 1 to September 30, 2025, marking a pivotal moment for...

Continue Reading
Empowering Change: The Critical Role of Health Equity Leadership

Updated Category News Views 253

Fostering Collaboration for Health Equity The upcoming National Summit hosted by the Black Directors Health Equity Agenda (BDHEA) aims to unite Board Directors and senior leaders in tackling the challenges facing health equity in America. This empowering event engages stakeholders from various sectors to drive conversation and action towards better healthcare outcomes for...

Continue Reading
Clorox Prepares for Upcoming Q2 Fiscal Year 2026 Webcast

Updated Category News Views 186

Clorox Announces Its Second-Quarter Fiscal Year 2026 Webcast The Clorox Company (NYSE: CLX) is set to release its financial results for the second quarter of the fiscal year 2026 on a date that is anticipated eagerly by investors and stakeholders alike. This eagerly awaited webcast will provide essential insights into the company’s performance and strategic direction....

Continue Reading
IgniteData Welcomes Dr. Jose Galvez as New CMIO for Growth

Updated Category News Views 461

IgniteData's Strategic Appointment to Enhance Clinical Data IgniteData, a frontrunner in clinical research, has made a significant move by welcoming Dr. Jose Galvez as its new Chief Medical Information Officer (CMIO). Dr. Galvez, who has a rich background including his tenure as Deputy Director of the FDA, brings two decades of expertise in clinical informatics and...

Continue Reading
Kalmar and Volvo Penta Join Forces in Engine Service Agreement

Updated Category News Views 76

Kalmar and Volvo Penta Strengthen Their Partnership Kalmar Corporation has recently made a significant move to enhance its service capabilities by entering into a new framework service agreement with Volvo Penta. This collaboration is designed to improve the performance and service quality of Volvo Penta engines used in Kalmar machines. As a result of this agreement,...

Continue Reading